← All stocks

Envista Holdings Corp

NVST Scheduled selling only
CIK 0001757073 #1458 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$510.25K
$220.00K on a plan · $290.25K straight out of an exercise
Sold at will
$0.00
0 of 3 sales
Net
−$510.25K
$0.00 against sales at will

By person

16 insiders · 3 transactions
13.7×

Paul Keel holds 13.7 times base salary in stock. $15.16M of shares against $1.10M in salary for 2025.

Salary from the company's own proxy. The shares are what Paul Keel last reported holding, valued at $27.50, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Reis Mischa
SVP, Strategy & Bus. Dev.
$510.25K (3) scheduled
−$510.25K
27,321
0.0170%
$751.33K
−36.0%
Keel Paul A
Chief Executive Officer
551,304
0.3432%
$15.16M
+36.9%
Hammes Eric D.
Chief Financial Officer
99,913
0.0622%
$2.75M
+12.6%
Huennekens R Scott
Director
82,105
0.0511%
$2.26M
+48.9%
Nance Mark E
General Counsel
81,252
0.0506%
$2.23M
+41.4%
Hulit Barbara B.
Director
79,820
0.0497%
$2.20M
+15.1%
Nilsson Stefan
President, Nobel Biocare
61,560
0.0383%
$1.69M
+35.4%
Carruthers Wendy
Director
59,940
0.0373%
$1.65M
+49.3%
TSINGOS CHRISTINE A
Director
59,930
0.0373%
$1.65M
+49.3%
Kaabi Faez C
Chief Accounting Officer
58,552
0.0365%
$1.61M
+31.2%
Raskas Daniel
Director
54,010
0.0336%
$1.49M
+57.8%
GALLAHUE KIERAN
Director
54,010
0.0336%
$1.49M
+57.8%
Jain Vivek
Director
52,945
0.0330%
$1.46M
+59.6%
Acurio Veronica
President, Orthodontics
48,806
0.0304%
$1.34M
+7.4%
Befidi Robert
President, Diagnostics
45,785
0.0285%
$1.26M
+15.1%
Pierce James Andrew
Director
18,485
0.0115%
$508.34K
Insider
Date
Role
Action
Shares
Price
Amount
Reis Mischa
20 Aug 2026
SVP, Strategy & Bus. Dev.
Sold on a plan
8,000
$27.50
$220.00K
Reis Mischa
10 Feb 2026
SVP, Strategy & Bus. Dev.
Sold after exercise
5,634
$30.00
$169.02K
Reis Mischa
10 Feb 2026
SVP, Strategy & Bus. Dev.
Sold after exercise
4,041
$30.00
$121.23K

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 498,038
History held since 18 Sep 2019